Abstract is: A neuromuscular disease is any disease affecting the peripheral nervous system (PNS), the neuromuscular junction, or skeletal muscle, all of which are components of the motor unit. Damage to any of these structures can cause muscle atrophy and weakness. Issues with sensation can also occur. Neuromuscular diseases can be acquired or genetic. Mutations of more than 500 genes have shown to be causes of neuromuscular diseases. Other causes include nerve or muscle degeneration, autoimmunity, toxins, medications, malnutrition, metabolic derangements, hormone imbalances, infection, nerve compression/entrapment, comprised blood supply, and trauma.
| class of disease | Q112193867 |
| disease | Q12136 |
| peripheral neuropathy | Q945238 |
| musculoskeletal disorder | Q4116663 |
| P699 | Disease Ontology ID | DOID:440 |
| P2888 | exact match | http://identifiers.org/doid/DOID:440 |
| http://purl.obolibrary.org/obo/DOID_440 | ||
| http://www.orpha.net/ORDO/Orphanet_68381 | ||
| P11956 | Experimental Factor Ontology ID | 1001902 |
| P646 | Freebase ID | /m/0c818v |
| P4229 | ICD-10-CM | G70.9 |
| P1692 | ICD-9-CM | 358 |
| 358.9 | ||
| P3827 | JSTOR topic ID (archived) | neuromuscular-diseases |
| P8408 | KBpedia ID | NeuromuscularDisease |
| P486 | MeSH descriptor ID | D009468 |
| P672 | MeSH tree code | C10.668 |
| P6366 | Microsoft Academic ID | 2776356578 |
| P5270 | Mondo ID | MONDO_0019056 |
| P1368 | National Library of Latvia ID | 000125197 |
| P691 | NL CR AUT ID | ph115442 |
| P10283 | OpenAlex ID | C2776356578 |
| P1550 | Orphanet ID | 68381 |
| P2892 | UMLS CUI | C0027868 |
| P11143 | WikiProjectMed ID | Neuromuscular disease |
| P2293 | genetic association | TRPV4 | Q15324120 |
| P1995 | health specialty | neurology | Q83042 |
| neuromuscular medicine | Q7002432 | ||
| P276 | location | human musculoskeletal system | Q726543 |
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| P910 | topic's main category | Category:Neuromuscular diseases | Q98971873 |
| Q112501550 | Bernd Rautenstrauß |
| Q38545674 | Daniel José Moreno Fernández Ayala |
| Q47568123 | Gita Ramdharry |
| Q46718814 | Hugh J. McMillan |
| Q124741049 | James W. Russell |
| Q112541707 | Jasper R. Daube |
| Q112544397 | József Laczkó |
| Q116149661 | Klaus Schimrigk |
| Q91245722 | Peter B Kang |
| Q124741486 | Rebecca Craik |
| Q37374003 | Simon C. Gandevia |
| Q126925043 | Umberto De Girolami |
| Q112504781 | Wolfgang Grisold |
| Q32425582 | Wolfgang Löscher |
| Q1052687 | Charcot–Marie–Tooth disease |
| Q5447191 | Fields' disease |
| Q11781607 | Native American myopathy |
| Q7559238 | Somatic dysfunction |
| Q18350119 | acute flaccid myelitis |
| Q18558067 | atrophic muscular disease |
| Q18556490 | central nervous system hereditary degenerative disease |
| Q55788493 | muscular channelopathy |
| Q6593390 | myokymia |
| Q55786149 | neuromuscular disease with dilated cardiomyopathy |
| Q7002430 | neuromuscular junction disease |
| Q55224527 | neuromuscular manifestations |
| Q18556574 | optic nerve astrocytoma |
| Q102297038 | paramyotonia congenita of Von Eulenburg |
| Q55785960 | qualitative or quantitative protein defects in neuromuscular diseases |
| Q122023736 | DNS kongres: medicína pohybového systému ve sportu: sborník abstrakt: 7. září 2018, Praha, Hotel Clarion |
| Q122042441 | Neuromuskulární choroby v kazuistikách |
| Q122124420 | Neuromuskulární kongres: 33. neuromuskulární sympozium: XXXIII. slovenská konferencia o neuromuskulárnych ochoreniach: 12.-13. května 2022, Orea Congress Hotel Brno: program, sborník abstrakt |
| Q122119585 | Zaznělo na 4. neuromuskulárním fóru: 23.-24.9.2021, OREA resort Santon Brno |
| Q122135265 | Zaznělo na Neuromuskulárním kongrese: Brno, 12.-13.5.2022 |
| Q97589676 | "A randomized trial of initiation of chronic non-invasive mechanical ventilation at home vs in-hospital in patients with Neuromuscular Disease and thoracic cage disorder": The Dutch Homerun Trial |
| Q92591231 | "Be an ambassador for change that you would like to see": a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease |
| Q37610585 | "Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders |
| Q50852840 | "Hospital at home" for neuromuscular disease patients with respiratory tract infection: a pilot study. |
| Q59327641 | 267. Viral Respiratory Infections in Children with Neuromuscular Disease and Chronic Lung Disease Hospitalized in the Pediatric Intensive Care Unit and Associated Antibiotic Use |
| Q24652718 | A Handheld Electrical Impedance Myography probe for the assessment of neuromuscular disease |
| Q44789232 | A case of congenital neuromuscular disease with uniform type 1 fiber |
| Q47655566 | A case of congenital neuromuscular disease with uniform type 1 fibers. |
| Q93621518 | A case of congenital neuromuscular disease with uniform type I fibers, abnormal mitochondrial network and jagged Z-line |
| Q36726900 | A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice |
| Q77897496 | A familial degenerative neuromuscular disease of Gelbvieh cattle |
| Q48482149 | A fatal neuromuscular disease in an adult patient after poliomyelitis in early childhood: consideration of the pathology of post-polio syndrome |
| Q41765695 | A new congenital neuromuscular disease with trilaminar muscle fibers |
| Q70679851 | A new hereditary neuromuscular disease in the dog breed "Gammel Dansk Honsehund". Genetic investigations |
| Q52881372 | A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene. |
| Q39121670 | A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland |
| Q37996979 | A review of pediatric palliative care service utilization in children with a progressive neuromuscular disease who died on a palliative care program |
| Q80397069 | A suspected inherited neuromuscular disease in Dorset Down sheep |
| Q38170698 | ALS and neuromuscular disease: in search of the Holy Grail |
| Q90379787 | Abdominal paradox encountered in neuromuscular disease: A possible clue for cor pulmonale |
| Q71193445 | Abnormal myomuscular junctions and AChE in a congenital neuromuscular disease |
| Q73954287 | Abnormal swallowing in central-nervous-system and neuromuscular disease |
| Q91340952 | Abstracts from "Imaging in Neuromuscular Disease 2019: Second International Conference on Imaging in Neuromuscular Disease, 17th - 19th November 2019 | Berlin, Germany" |
| Q86009721 | Abstracts from Muscle Study Group Meeting: Experimental Therapeutics Across the Spectrum of Neuromuscular Disease Snowbird Ski & Summer Resort Snowbird, UT, September 19-21, 2015 |
| Q37072936 | Acid maltase levels in muscle in heterozygous acid maltase deficiency and in non-weak and neuromuscular disease controls |
| Q46884863 | Acquired idiopathic laryngeal paralysis as a prominent feature of generalised neuromuscular disease in 39 dogs. |
| Q83153357 | Acquired laryngeal paralysis in dogs: evidence accumulating for a generalized neuromuscular disease |
| Q91465038 | Acquired undescended testis and possibly associated testicular torsion in children with cerebral palsy or neuromuscular disease |
| Q64086006 | Acute Flaccid Myelitis: Something Old and Something New |
| Q91457203 | Acute Manifestations of Neuromuscular Disease |
| Q92139703 | Acute flaccid myelitis and enterovirus D68: lessons from the past and present |
| Q98178100 | Advanced Skeletal Muscle Mass Reduction (Sarcopenia) Secondary to Neuromuscular Disease |
| Q64066498 | Advances in imaging of brain abnormalities in neuromuscular disease |
| Q37349510 | Advances in neuromuscular disease 2003: the year in review |
| Q62803093 | Advancing the role of electrodiagnostic techniques in equine neuromuscular disease |
| Q45982378 | Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. |
| Q84022345 | An exploratory study of physical activity and perceived barriers to exercise in ambulant people with neuromuscular disease compared with unaffected controls |
| Q71605661 | An improved method for muscle force assessment in neuromuscular disease |
| Q51796150 | An integrated motion capture system for evaluation of neuromuscular disease patients. |
| Q80471427 | An interesting study conducted in a group of immobile children with neuromuscular disease |
| Q67552303 | Analysis of neuromuscular disease |
| Q43002693 | Anesthetic case in a child with congenital neuromuscular disease with uniform type 1 fibers (CNMDU1). |
| Q74298337 | Another approach to ventilatory failure in neuromuscular disease |
| Q38734734 | Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease. |
| Q34080836 | Apolipoprotein E and neuromuscular disease: a critical review of the literature |
| Q71540385 | Application of benefit-to-cost analysis to an X-linked recessive cardiac and humeroperoneal neuromuscular disease |
| Q72134010 | Application of lectin cytochemistry to the study of human neuromuscular disease |
| Q71193417 | Application of the freeze fracture technique to the study of human neuromuscular disease |
| Q34553096 | Assessing neuromuscular disease with multifrequency electrical impedance myography |
| Q90671522 | Assessment of Respiratory Muscle Weakness in Subjects With Neuromuscular Disease |
| Q67252000 | Assessment of quadriceps femoris muscle atrophy and hypertrophy in neuromuscular disease in children |
| Q30465481 | Assessment of ventilatory function in patients with neuromuscular disease |
| Q55311682 | Assistive technology and supplementary treatment for individuals with Rett syndrome. |
| Q102371263 | Associations between polysomnography measurements and postoperative adverse respiratory events in children with neuromuscular disease |
| Q77108245 | Atypical retinitis pigmentosa, acanthrocytosis, and heredodegenerative neuromuscular disease |
| Q92236220 | Augmenting Cough via Home Ventilators in Subjects With Neuromuscular Disease: Simple, Effective, and Clever |
| Q98200793 | Augmenting Neuromuscular Disease Detection Using Optimally Parameterized Weighted Visibility Graph |
| Q100415724 | Author Correction: NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease |
| Q46625244 | Autoimmune neuromuscular disease induced by a preparation of choline acetyltransferase |
| Q28266146 | Autosomal dominant neuromuscular disease with cylindrical spirals |
| Q82704597 | Avoidance of tracheostomy in patients with neuromuscular disease |
| Q48476387 | Avoiding respiratory failure in neuromuscular disease: why is it not done? |
| Q57712572 | Being the lifeline: The parent experience of caring for a child with neuromuscular disease on home mechanical ventilation |
| Q37572954 | Biallelic SCN10A mutations in neuromuscular disease and epileptic encephalopathy |
| Q73176966 | Bibliography. Current world literature. Neuromuscular disease: muscle |
| Q80564499 | Bibliography. Current world literature. Neuromuscular disease: muscle |
| Q73176968 | Bibliography. Current world literature. Neuromuscular disease: nerve |
| Q81048258 | Bibliography. Current world literature. Neuromuscular disease: nerve |
| Q58184447 | Biomarkers research in neuromuscular disease Charcot-Marie-Tooth |
| Q35583470 | Blood loss during posterior spinal fusion surgery in patients with neuromuscular disease: is there an increased risk? |
| Q91129059 | Body composition in patients with primary neuromuscular disease assessed by dual energy X-ray absorptiometry (DXA) and three different bioimpedance devices |
| Q48806304 | Brain atrophy in congenital neuromuscular disease with uniform type 1 fibers |
| Q89187614 | Breathing with neuromuscular disease: Does compensatory plasticity in the motor drive to breathe offer a potential therapeutic target in muscular dystrophy? |
| Q91732551 | COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity |
| Q72246532 | Calcium channels and neuromuscular disease |
| Q33147218 | Cardiac Features of an Unusual X-Linked Humeroperoneal Neuromuscular Disease |
| Q83980316 | Cardiac MRI versus echocardiography in assessing noncompaction in children without neuromuscular disease |
| Q88286146 | Cardiac Manifestations of Neuromuscular Disease |
| Q36949612 | Cardiac and noncardiac, particularly neuromuscular, disease with troponin-T positivity |
| Q64864724 | Case of oculocraniosomatic neuromuscular disease associated with parkinsonism with special reference to catecholamine metabolism |
| Q47643421 | Case of paediatric neuromuscular disease with a surprising clinical outcome: time to challenge the dogma? |
| Q68862266 | Caveolae preservation in the characterization of human neuromuscular disease |
| Q73851194 | Central core disease and congenital neuromuscular disease with uniform type 1 fibers in one family |
| Q70223614 | Chest wall mechanics in neuromuscular disease |
| Q72915317 | Chest wall motion before and during mechanical ventilation in children with neuromuscular disease |
| Q68098868 | Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to "non-Duchenne muscular dystrophy" |
| Q69512507 | Childhood neuromuscular disease with rimmed vacuoles |
| Q72355847 | Chronic denervation caused by botulinum neurotoxin as a model of a neuromuscular disease |
| Q36894858 | Chronic pain in neuromuscular disease: pain site and intensity differentially impacts function |
| Q81329240 | Chronic pain in persons with neuromuscular disease |
| Q35536005 | Clinical and pathological observations in neuromuscular disease: a review |
| Q38769729 | Clinical course of growth in patients with congenital neuromuscular disease in a single multidisciplinary neuromuscular clinic |
| Q67649536 | Clinical examination of patients with neuromuscular disease |
| Q101219615 | Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease |
| Q67474499 | Clinical interpretations of the measurement of folic acid and vitamin B12 in neuromuscular disease |
| Q68593097 | Clinical trials in neuromuscular disease |
| Q70956677 | Clinical varieties of neuromuscular disease in debrancher deficiency |
| Q70427091 | Club foot: a neuromuscular disease |
| Q38134965 | Cochrane 20 years on: the Cochrane Neuromuscular Disease Group |
| Q84596627 | Cognition in neuromuscular disease |
| Q90210339 | Combined noninvasive ventilation and mechanical insufflator-exsufflator for acute respiratory failure in patients with neuromuscular disease: effectiveness and outcome predictors |
| Q93052198 | Comparison of Two Cough-Augmentation Techniques Delivered by a Home Ventilator in Subjects With Neuromuscular Disease |
| Q92107667 | Comparison of arterial and venous blood gases in patients with obesity hypoventilation syndrome and neuromuscular disease |
| Q39660858 | Congenital and acquired neuromuscular disease of young dogs and cats |
| Q73362015 | Congenital cataract as the first symptom of a neuromuscular disease caused by a novel single large-scale mitochondrial DNA deletion |
| Q80214283 | Congenital diaphragm weakness without neuromuscular disease |
| Q39267404 | Congenital neuromuscular disease with type I fibre hypotrophy, ophthalmoplegia and myofibril degeneration |
| Q56906866 | Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation |
| Q46707994 | Congenital neuromuscular disease with uniform type-1 fibers, presenting early stage dystrophic muscle pathology |
| Q70159274 | Congestive cardiomyopathy, peripheral neuropathy, abnormal CT findings, neurosensory deafness, cerebellar ataxia and ophthalmoplegia in oculocraniosomatic neuromuscular disease with ragged red fibers |
| Q42541405 | Connecting Canadians with neuromuscular disease to research |
| Q36772150 | Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). |
| Q83172098 | Continuous critical care and long-term noninvasive ventilatory support for patients with neuromuscular disease |
| Q47749557 | Continuous noninvasive ventilation for patients with neuromuscular disease and spinal cord injury |
| Q44831761 | Contraception and screening for cervical and breast cancer in neuromuscular disease: a retrospective study of 50 patients monitored at a clinical reference centre |
| Q73433459 | Creatine monohydrate increases strength in patients with neuromuscular disease |
| Q81213610 | Critical burn patient with an unknown neuromuscular disease |
| Q46500362 | Critical burn patient with an unknown neuromuscular disease: conclusion |
| Q35092397 | Critical care management of neuromuscular disease, including long-term ventilation |
| Q40585129 | Critical illness neuromuscular disease in children manifested as ventilatory dependence |
| Q34517838 | Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects |
| Q68671347 | Current concepts in diagnosis: electromyography in the diagnosis of neuromuscular disease |
| Q33932218 | Current concepts of respiratory complications of neuromuscular disease in children |
| Q95439351 | Current world literature. Neuromuscular disease: muscle |
| Q38271515 | Cystic fibrosis newborn screening: a model for neuromuscular disease screening? |
| Q46713907 | D-penicillamine-induced neuromuscular disease in guinea pigs |
| Q36180071 | DCT domain feature extraction scheme based on motor unit action potential of EMG signal for neuromuscular disease classification |
| Q28542539 | Decreased variability of the 6-minute walk test by heart rate correction in patients with neuromuscular disease |
| Q27003427 | Defective membrane remodeling in neuromuscular diseases: insights from animal models |
| Q35543993 | Degenerative neurological and neuromuscular disease in young rottweilers |
| Q68519862 | Dental and occlusal characteristics of children with neuromuscular disease |
| Q67765356 | Depressed ventilatory response in oculocraniosomatic neuromuscular disease |
| Q58283133 | Depression Misdiagnosed as Neuromuscular Disease: Case Reports and Review |
| Q39386238 | Developing multidisciplinary clinics for neuromuscular care and research. |
| Q50597315 | Development and testing psychometric properties of an ICF-based health measure: The Neuromuscular Disease Impact Profile. |
| Q44092020 | Development and validation of a motor function classification in patients with neuromuscular disease: the NM-score |
| Q85527047 | Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the Neuromuscular Disease Swallowing Status Scale (NdSSS) |
| Q70791438 | Diagnosis and treatment of neuromuscular disease |
| Q74584985 | Diagnostic trap and difficulties of genetic counseling in a family with neuromuscular disease carriers |
| Q47669955 | Diaphragm: Pathophysiology and Ultrasound Imaging in Neuromuscular Disorders |
| Q92178274 | Different walk aids on gait parameters and kinematic analysis of the pelvis in patients with Adult Neuromuscular Disease |
| Q72763762 | Differential diagnosis of neuromuscular disease by clinical evaluation |
| Q78149986 | Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease |
| Q38039566 | Disease burden in neuromuscular disease: the role of chronic pain |
| Q82701389 | Diurnal hypercapnia in patients with neuromuscular disease |
| Q30829825 | Do Psychosocial Interventions Improve Quality of Life and Wellbeing in Adults with Neuromuscular Disorders? A Systematic Review and Narrative Synthesis. |
| Q89797758 | Does non-invasive ventilation compared to invasive ventilation improve short term survival for acute respiratory failure in people with neuromuscular disease and chest wall disorders? A Cochrane Review summary with commentary |
| Q85024143 | Dying young: eliminating racial disparities in neuromuscular disease outcomes |
| Q73395898 | Dynamics of hip joint remodeling after Chiari osteotomy. 10 patients with neuromuscular disease followed for 8 years |
| Q60054869 | Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease |
| Q84458524 | Dystrobrevin isoform expression in patients with neuromuscular disease |
| Q77055170 | ELECTRODIAGNOSIS OF NEUROMUSCULAR DISEASE |
| Q30832937 | Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR). |
| Q72348570 | Early-onset respiratory failure caused by severe congenital neuromuscular disease |
| Q60930991 | Editorial announcing PubMed indexing of Degenerative Neurological and Neuromuscular Disease |
| Q95447158 | Effect of Long-Term Mechanical Ventilation (LTMV) Part 1 – Neuromuscular Disease or Central Respiratory Failure |
| Q38084354 | Effect of home mechanical in-exsufflation on hospitalisation and life-style in neuromuscular disease: a pilot study |
| Q88183292 | Effect of muscle weakness distribution on balance in neuromuscular disease |
| Q70719564 | Effect of training on the exercise responses of neuromuscular disease patients |
| Q73651491 | Effect of upper respiratory tract infection in patients with neuromuscular disease |
| Q35544490 | Effectiveness and cost-effectiveness of a self-management group program to improve social participation in patients with neuromuscular disease and chronic fatigue: protocol of the Energetic study |
| Q46007402 | Effects of respiratory muscle training on pulmonary functions in patients with slowly progressive neuromuscular disease: a randomized controlled trial. |
| Q59322873 | Efficient computer operation for users with a neuromuscular disease with OnScreenDualScribe |
| Q39845196 | Electrocardiographic abnormalities in pediatric neuromuscular disease: a review |
| Q77810818 | Electrodiagnosis in neuromuscular disease |
| Q71387581 | Electrodiagnostic studies in neuromuscular disease |
| Q81835315 | Electrodiagnostic studies in neuromuscular disease |
| Q79002512 | Electrodiagnostic testing in neuromuscular disease |
| Q68845468 | Electromyography in children: indications and use. Apropos of 383 cases |
| Q74646323 | Electromyography of the diaphragm in neuromuscular disease |
| Q84957483 | Electrophysiological, pathological, and molecular study in diagnosis of neuromuscular disease |
| Q47760084 | Estimate of daily calorie needs for a neuromuscular disease patient receiving noninvasive ventilation |
| Q48583361 | Ethical considerations in paediatric neurology: neuromuscular disease and epilepsy |
| Q99583036 | Evaluation of assessment of caregiver experience with neuromuscular disease: reliability and responsiveness of a new caregiver-reported outcome measure in patients with cerebral palsy |
| Q71466490 | Evaluation of pulmonary function in neuromuscular disease |
| Q102054263 | Evaluation of the Core Formation Process in Congenital Neuromuscular Disease With Uniform Type 1 Fiber and Central Core Disease |
| Q39322123 | Exercise and neuromuscular disease |
| Q82947414 | Exercise in neuromuscular disease |
| Q103836793 | Exome sequencing for diagnosing uncommon paediatric neuromuscular disease |
| Q34490328 | Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings. |
| Q44164156 | Experienced stigmatization reduced quality of life of patients with a neuromuscular disease: a cross-sectional study |
| Q112948537 | Experiences of young New Zealanders with progressive neuromuscular conditions : quality of life and mental health |
| Q58104620 | Exploiting the heightened phase synchrony in patients with neuromuscular disease for the establishment of efficient motor imagery BCIs |
| Q64236140 | Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI |
| Q72016991 | Expression of the 43 kDa dystrophin-associated glycoprotein in human neuromuscular disease |
| Q28394841 | Facilitators and Barriers to Noninvasive Ventilation Adherence in Youth with Nocturnal Hypoventilation Secondary to Obesity or Neuromuscular Disease |
| Q71397241 | Familial intrahepatic cholestasis associated with progressive neuromuscular disease and vitamin E deficiency |
| Q70022291 | Familial neuromuscular disease with "myotubes" |
| Q70711932 | Familial neuromuscular disease with nonketotic hyperglycinemia |
| Q47906821 | Familial neuromuscular disease with tubular aggregates |
| Q67016906 | Familial neuromuscular disease with type 1 fiber hypoplasia, tubular aggregates, cardiomyopathy, and myasthenic features |
| Q48504538 | Familial oculocranioskeletal neuromuscular disease with abnormal muscle mitochondria |
| Q44796362 | Familial oculocraniosomatic neuromuscular disease with ragged red fibers |
| Q69593345 | Family stress with chronic childhood illness: cystic fibrosis, neuromuscular disease, and renal disease |
| Q33666033 | Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease |
| Q54261799 | Flexible DNA: genetically unstable CTG.CAG and CGG.CCG from human hereditary neuromuscular disease genes. |
| Q92460557 | Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease |
| Q53557981 | Forty years of neuromuscular disease: a historical perspective. |
| Q72127246 | Free fatty acid concentrations in normal and diseased human muscle and in blood sera from patients with neuro-muscular disease |
| Q41915467 | From poliomyelitis to myopathies: management of respiratory insufficiency in neuromuscular disease |
| Q28081198 | Frontotemporal dementia: a bridge between dementia and neuromuscular disease |
| Q69050699 | Functional ability and equipment use among patients with neuromuscular disease |
| Q93655118 | Generalized muscle stiffness and spontaneous electromyographic discharges in neuromuscular disease of parathyroid gland hypofunction |
| Q35073229 | Genetic background alters the severity and onset of neuromuscular disease caused by the loss of ubiquitin-specific protease 14 (usp14) |
| Q102386076 | Genotype-Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry |
| Q74654826 | Glycocyamine betaine as an adjunct in the treatment of neuromuscular disease patients |
| Q44633820 | HIV neuromuscular disease and mitochondrial function |
| Q40638027 | Hawaii's Neuromuscular Disease Biopsy Registry. A quarter-century compilation of muscle biopsy diagnoses in Hawaii |
| Q47419350 | Height measurement of patients with neuromuscular disease and contractures |
| Q48533203 | Hereditary neuromuscular disease and multicomposite subjective health status: feasibility, internal consistency and test-retest reliability in the French version of the Nottingham Health Profile, the ISPN. |
| Q70222314 | High-frequency ultrasonography of skeletal muscle in children with neuromuscular disease |
| Q69634648 | Histochemical changes in skeletal muscles of four male horses with neuromuscular disease |
| Q52846114 | Hospice provision and usage amongst young people with neuromuscular disease in the United Kingdom. |
| Q42597956 | How persons with a neuromuscular disease perceive employment participation: a qualitative study. |
| Q35467194 | Human T cell leukaemia virus type I associated neuromuscular disease causing respiratory failure |
| Q70489338 | Human muscle carbonic anhydrase III (CA-III). Purification, immunohistochemical localization in the human skeletal muscle and its clinical application to the neuromuscular disease |
| Q71234841 | Hyperkinetic circulation during exercise in neuromuscular disease |
| Q78783538 | Hypnosis, an adjunct in the treatment of neuromuscular disease |
| Q67421201 | Hypometabolism of nonthyroid origin in oculocraniosomatic neuromuscular disease |
| Q52849900 | Hypoxic challenge flight assessments in patients with severe chest wall deformity or neuromuscular disease at risk for nocturnal hypoventilation. |
| Q49342913 | Imaging of respiratory muscles in neuromuscular disease: A review |
| Q96684055 | Impact of Interface Type on Noninvasive Ventilation Efficacy in Patients With Neuromuscular Disease: A Randomized Cross-Over Trial |
| Q87704171 | Impact of exercise-induced fatigue on the strength, postural control, and gait of children with a neuromuscular disease |
| Q60927028 | Improvement of Peak Cough Flow After the Application of a Mechanical In-exsufflator in Patients With Neuromuscular Disease and Pneumonia: A Pilot Study |
| Q72665616 | In vitro skeletal muscle protein and RNA incorporation in neuromuscular disease |
| Q83152922 | In-hospital death while awaiting cardioverter/defibrillator in neuromuscular disease |
| Q37441312 | Increasing Role of Titin Mutations in Neuromuscular Disorders. |
| Q69453909 | Intermittent negative pressure ventilation in the treatment of respiratory failure in progressive neuromuscular disease |
| Q91537576 | Interprofessional Care for Neuromuscular Disease |
| Q24240063 | Interventions for increasing ankle range of motion in patients with neuromuscular disease |
| Q24243487 | Interventions for increasing ankle range of motion in patients with neuromuscular disease |
| Q51785190 | Intravenous immunoglobulin for neuromuscular disease: costs, benefits and reimbursement. |
| Q59526206 | Introducing the online version of the gene table for neuromuscular disease (nuclear genes only) |
| Q24240146 | Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders |
| Q47376792 | Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders. |
| Q33852802 | Investigating the minimum required number of genes for the classification of neuromuscular disease microarray data. |
| Q92341773 | Investigating the role of genetic counseling in neuromuscular disease considering life events |
| Q6294897 | Journal of Cachexia, Sarcopenia and Muscle |
| Q87202388 | Juvenile 'cryptogenic' stroke from noncompaction in a neuromuscular disease |
| Q72890208 | Kineceptic ankle-foot orthosis in neuromuscular disease |
| Q60725474 | King's College London Neuromuscular Disease Symposium, November 2002 - an unusual cause of speech and swallowing difficulty |
| Q36013198 | Kyphoscoliosis associated with congenital neuromuscular disease with uniform type 1 fibers |
| Q97525441 | Laying the foundation for neuromuscular disease gene therapy |
| Q87276548 | Leriche-syndrome despite regular sport and non-compaction suggest neuromuscular disease |
| Q45383823 | Letter to the Editor: Successful Extubation After Weaning Failure by Noninvasive Ventilation in Patients With Neuromuscular Disease - Do We Appreciate the Bigger Picture? |
| Q69781650 | Letter: Hypercalcemia and neuromuscular disease |
| Q48156939 | Leukoencephalopathy in oculocraniosomatic neuromuscular disease with ragged-red fibers. Mitochondrial abnormalities demonstrated by computerized tomography |
| Q51674223 | Lifestyle Implications of Home Mechanical Insufflation-Exsufflation for Children With Neuromuscular Disease and Their Families. |
| Q46603425 | Limb contractures in progressive neuromuscular disease and the role of stretching, orthotics, and surgery |
| Q71380378 | Living with progressive childhood illness: parental management of neuromuscular disease |
| Q91129387 | Long-Term Mechanical Insufflation-Exsufflation Cough Assistance in Neuromuscular Disease: Patterns of Use and Lessons for Application |
| Q40599844 | Long-term care, rehabilitation, and legal and ethical considerations in the management of neuromuscular disease with respiratory dysfunction |
| Q47876468 | Long-term day-case treatment of peripheral neuromuscular disease with intravenous immunoglobulin: the practice of a regional day-case service in Preston, Lancashire. |
| Q70377340 | Long-term mechanical ventilation in infants with neuromuscular disease |
| Q92412903 | Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease |
| Q101406787 | Lower Extremity Lymphatic Function in Nonambulatory Patients with Neuromuscular Disease |
| Q81807783 | Lung insufflation capacity in neuromuscular disease |
| Q91982537 | Lung ultrasound: A useful additional tool in clinician's hands to identify pulmonary atelectasis in children with neuromuscular disease |
| Q50622977 | MICU1 mutation: a genetic cause for a type of neuromuscular disease in children. |
| Q47103310 | MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide |
| Q31019878 | MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study. |
| Q34260138 | MRI of neuromuscular disease: the basics. |
| Q37123866 | MRI quantifies neuromuscular disease progression |
| Q92282059 | MYL2-associated congenital fiber-type disproportion and cardiomyopathy with variants in additional neuromuscular disease genes; the dilemma of panel testing |
| Q82863860 | Maintaining an "oral tradition": specific equipment requirements for mouthpiece ventilation instead of tracheostomy for neuromuscular disease |
| Q70258872 | Mallory body-like inclusions in a hereditary congenital neuromuscular disease |
| Q51022097 | Management and long-term outcome of patients with chronic neuromuscular disease admitted to the intensive care unit for acute respiratory failure: a single-center retrospective study. |
| Q77810838 | Management of pulmonary complications in neuromuscular disease |
| Q79715455 | Managing the patient with neuromuscular disease and respiratory insufficiency |
| Q71848500 | Maximal static respiratory pressures in generalized neuromuscular disease |
| Q37704865 | Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature |
| Q73814441 | Maximum insufflation capacity: vital capacity and cough flows in neuromuscular disease |
| Q96291179 | Measures of nocturnal oxyhemoglobin desaturation in children with neuromuscular disease or Prader-Willi syndrome |
| Q89590136 | Measures of respiratory inductance plethysmography (RIP) in children with neuromuscular disease |
| Q37693358 | Measuring Habitual Physical Activity in Neuromuscular Disorders: A Systematic Review |
| Q81357535 | Measuring inspiratory muscle strength in neuromuscular disease: one test or two? |
| Q70401169 | Mechanical assistance in chronic respiratory insufficiency due to neuromuscular disease |
| Q47860353 | Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections |
| Q73435270 | Mechanism of CO(2) retention in patients with neuromuscular disease |
| Q37034599 | Mechanisms of Sleep-Disordered Breathing in Chronic Neuromuscular Disease: Implications for Management |
| Q40215669 | Medical School Hotline: Medical Student Insights on Pediatric Neuromuscular Disease in Hawai'i |
| Q72228406 | Membership of a patients' association and well-being. A study into the relationship between membership of a patients' association, fellow-patient contact, information received, and psychosocial well-being of people with a neuromuscular disease |
| Q59557680 | Methodology and Design of a National Epidemiological Study on Adult Neuromuscular Disease |
| Q64047467 | Methodology for astronaut reconditioning research |
| Q100695096 | Micro (mRNA) molecules could pack a big punch in the fight against neuromuscular disease |
| Q37079469 | Miniature end-plate potentials in neuromuscular disease: an electrophysiological investigation of motor-point muscle biopsies |
| Q66954032 | Mobilization of a patient with progressive neuromuscular disease and lower extremity fractures |
| Q37353896 | Molecular mechanisms of treadmill therapy on neuromuscular atrophy induced via botulinum toxin A. |
| Q67244451 | Morphologic and metabolic studies in a case of oculo-cranio-somatic neuromuscular disease |
| Q48053925 | Mouse p150Glued (dynactin 1) cDNA sequence and evaluation as a candidate for the neuromuscular disease mutation mnd2. |
| Q39033666 | Mouthpiece ventilation and complementary techniques in patients with neuromuscular disease: A brief clinical review and update |
| Q36881612 | Multi-minicore Disease |
| Q70504318 | Multiple myeloma occurring in association with a preexisting neuromuscular disease (progressive muscular dystrophy). A chance occurrence or a nosological entity? |
| Q88253389 | Muscle Study Group Annual Meeting, Models of Neuromuscular Disease Across the Lifespan, Snowbird Ski & Summer Resort, Snowbird, UT, September 24-26, 2016 |
| Q69615059 | Muscle biopsy in neuromuscular disease |
| Q67716498 | Muscle carnitine levels in neuromuscular disease |
| Q67011177 | Muscle fiber hypotrophy with intact neuromuscular junctions: A study of a patient with congenital neuromuscular disease and ophthalmoplegia |
| Q68130994 | Muscle imaging in neuromuscular disease using computerized real-time sonography |
| Q51666996 | Muscle impairment in neuromuscular disease using an expiratory/inspiratory pressure ratio. |
| Q37041489 | Muscle nuclear size in neuromuscular disease |
| Q77982620 | Muscle ultrasound in the assessment of suspected neuromuscular disease in childhood |
| Q37056854 | Musculoskeletal complications of neuromuscular disease in children |
| Q99551101 | NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease |
| Q108819145 | NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease |
| Q34008060 | Nasal ventilation in progressive neuromuscular disease: experience in adults and adolescents. |
| Q28212167 | Nature and significance of pentosuria in neuromuscular disease |
| Q73912560 | Nature and significance of pentosuria in neuromuscular disease |
| Q69993815 | Neurological and neuromuscular disease |
| Q47698338 | Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection |
| Q101470813 | Neuromuscular Disease Affecting the Larynx |
| Q100447230 | Neuromuscular Disease Detection Employing Deep Feature Extraction from Cross Spectrum Images of Electromyography Signals |
| Q59876219 | Neuromuscular Disease Management and Rehabilitation, Part I: Diagnostic and Therapy Issues |
| Q47756515 | Neuromuscular Disease Models and Analysis |
| Q52740398 | Neuromuscular Disease and Military Personnel |
| Q40113415 | Neuromuscular Disease and the Chest |
| Q39319929 | Neuromuscular Disease in Secondary Hyperparathyroidism |
| Q67324423 | Neuromuscular Disease in Tertiary Hyperparathyroidism |
| Q34537269 | Neuromuscular Disease in the Neurointensive Care Unit. |
| Q47316106 | Neuromuscular Disease: Cardiac Manifestations and Sudden Death Risk |
| Q1981326 | Neuromuscular Disorders |
| Q39955357 | Neuromuscular disease and anaesthesia |
| Q38083050 | Neuromuscular disease and anesthesia |
| Q33733240 | Neuromuscular disease and calcium channels |
| Q33752978 | Neuromuscular disease and extubation dysphagia |
| Q33778225 | Neuromuscular disease and hypoventilation |
| Q37223184 | Neuromuscular disease and respiratory failure |
| Q38224298 | Neuromuscular disease and respiratory physiology in children: putting lung function into perspective |
| Q38002276 | Neuromuscular disease and the pulmonologist |
| Q36293626 | Neuromuscular disease as the cause of late clubfoot relapses: report of 4 cases. |
| Q83158851 | Neuromuscular disease associated with glycogen storage in a Spanish-bred filly |
| Q36577983 | Neuromuscular disease causing acute respiratory failure |
| Q45814319 | Neuromuscular disease classification system. |
| Q70792911 | Neuromuscular disease due to tobacco use |
| Q41779612 | Neuromuscular disease in a dog. |
| Q39940409 | Neuromuscular disease in dogs: some aspects of its investigation and diagnosis |
| Q35003831 | Neuromuscular disease in patients with steatorrhoea |
| Q69735020 | Neuromuscular disease in primary hyperparathyroidism |
| Q78902849 | Neuromuscular disease in relation to nutrition |
| Q51140677 | Neuromuscular disease in respiratory and critical care medicine. |
| Q37455254 | Neuromuscular disease in the dialysis patient: an update for the nephrologist |
| Q79758455 | Neuromuscular disease in young snowshoe cats |
| Q46098343 | Neuromuscular disease management and rehabilitation, part II: specialty care and therapeutics |
| Q98575078 | Neuromuscular disease modeling on a chip |
| Q82250931 | Neuromuscular disease models and analysis |
| Q37653621 | Neuromuscular disease of the gastrointestinal tract |
| Q73768784 | Neuromuscular disease of the urinary tract in infants and children |
| Q84775653 | Neuromuscular disease presentation with three genetic defects involving two genomes |
| Q72511516 | Neuromuscular disease with type I fiber atrophy, central nuclei, and myotube-like structures |
| Q36683053 | Neuromuscular disease, respiratory failure and cor pulmonale |
| Q52423452 | Neuromuscular disease: CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy. |
| Q52424702 | Neuromuscular disease: Genome editing shows promise in an in vivo model of Duchenne muscular dystrophy. |
| Q84189835 | Neuromuscular disease: IVIg for neuromuscular disease-effective but expensive |
| Q53930323 | Neuromuscular disease: Mitochondrial dysfunction could precipitate motor neuron loss in spinal muscular atrophy. |
| Q50500127 | Neuromuscular disease: Muscular dystrophy--something new on God's green earth? |
| Q50075681 | Neuromuscular disease: Tadalafil fails to halt the progression of Duchenne muscular dystrophy |
| Q87342675 | Neuromuscular disease: muscle |
| Q38067198 | Neuromuscular disease: new insights and avenues for therapy. |
| Q76382650 | Neuromuscular disease: recognition and therapeutic options |
| Q40519950 | Neuromuscular disease: rehabilitation and electrodiagnosis. 1. Anatomy and physiology of nerve and muscle |
| Q40519938 | Neuromuscular disease: rehabilitation and electrodiagnosis. 2. Nerve disease |
| Q40519943 | Neuromuscular disease: rehabilitation and electrodiagnosis. 3. Muscle disease |
| Q38021997 | Neuromuscular electrical stimulation for skeletal muscle function |
| Q26829886 | Neurotoxicity in snakebite--the limits of our knowledge |
| Q33694097 | Neurotrophic factors and neuromuscular disease: I. General comments, the neurotrophin family, and neuropoietic cytokines |
| Q66925281 | New York University utilizes electromyography to detect carriers of neuromuscular disease |
| Q39292406 | New generation emerging technologies for neurorehabilitation and motor assistance |
| Q42388468 | New treatments for neuromuscular disease: optimism and obstacles |
| Q89689467 | Newer Immunotherapies for the Treatment of Acute Neuromuscular Disease in the Critical Care Unit |
| Q36292736 | Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth |
| Q38580541 | Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature. |
| Q74790206 | Nocturnal respiratory failure as an indication of noninvasive ventilation in the patient with neuromuscular disease |
| Q104488701 | Non-invasive Ventilation in Children With Neuromuscular Disease |
| Q73443957 | Non-invasive ventilation in neuromuscular disease |
| Q81422851 | Noncompaction and neuromuscular disease with positive troponin-T in a nonagenerian |
| Q42135320 | Noninvasive Assessment of Neuromuscular Disease in Dogs: Use of the 6-minute Walk Test to Assess Submaximal Exercise Tolerance in Dogs with Centronuclear Myopathy |
| Q42048879 | Noninvasive Respiratory Management of Patients With Neuromuscular Disease |
| Q88740382 | Noninvasive Ventilation for Neuromuscular Disease |
| Q85954511 | Noninvasive respiratory management and diaphragm and electrophrenic pacing in neuromuscular disease and spinal cord injury |
| Q80476684 | Noninvasive ventilation for patients with neuromuscular disease and acute respiratory failure |
| Q36546721 | Noninvasive ventilation in neuromuscular disease: equipment and application. |
| Q56459981 | Nonprogressive Congenital Neuromuscular Disease With Uniform Type 1 Fiber |
| Q71094250 | Nonprogressive congenital neuromuscular disease with uniform type 1 fiber |
| Q57640328 | Novel Mitochondrial Transfer RNAPhe Gene Mutation Associated With Late-Onset Neuromuscular Disease |
| Q85848827 | Novel molecular mechanisms of neuromuscular disease: implications for therapy. Abstracts of the Muscle Study Group Meeting. September 16-18, 2013. Oxford, United Kingdom |
| Q45193621 | Occult neuromuscular disease in 100 consecutive patients with scoliosis |
| Q66954234 | Oculocraniosomatic neuromuscular disease |
| Q67716304 | Oculocraniosomatic neuromuscular disease with "ragged-red" fibers (Olson)--a case study |
| Q50643739 | Oculocraniosomatic neuromuscular disease with "ragged-red" fibers. |
| Q52110759 | Oculocraniosomatic neuromuscular disease with hypoparathyroidism. |
| Q92611056 | On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease |
| Q48610826 | Ophthalmoplegia in congenital neuromuscular disease with uniform type 1 fiber |
| Q71709271 | Optimization of force in the Wingate Test for children with a neuromuscular disease |
| Q38145146 | Organelle pathology in metabolic neuromuscular disease: an overview |
| Q70020780 | Origin and significance of small muscle fibres in neuromuscular disease |
| Q66927211 | Orthopedic procedures in neuromuscular disease |
| Q38538591 | Outcome measures in neuromuscular disease: is the world still flat? |
| Q35278182 | Outcome of children with neuromuscular disease admitted to paediatric intensive care |
| Q60978320 | P230 Facilitating End-Of-Life Discussions in Users of Home Mechanical Ventilation That Have a Life-Limiting Neuromuscular Disease |
| Q39347039 | Pain and neuromuscular disease: the results of a survey |
| Q34528306 | Pain in youths with neuromuscular disease |
| Q51876628 | Paraneoplastic neuromuscular disease in lung large cell neuroendocrine carcinoma. |
| Q79232832 | Patient with adult-onset congenital neuromuscular disease with uniform type 1 fibers |
| Q44167333 | Patient-controlled positive end-expiratory pressure with neuromuscular disease: effect on speech in patients with tracheostomy and mechanical ventilation support |
| Q91113039 | Patterns of healthcare utilisation for respiratory complications of adults with neuromuscular disease: a population study |
| Q68051934 | Patterns of selective involvement of thigh muscles in neuromuscular disease |
| Q92554551 | Pediatric Pulmonology Year in Review 2018: Rare lung disease, neuromuscular disease, and diagnostic testing |
| Q74364282 | Perception of dyspnea in patients with neuromuscular disease |
| Q48561944 | Perioperative care of patients with neuromuscular disease and dysfunction |
| Q85396005 | Physical Medicine and Rehabilitation Clinics of North America. Neuromuscular disease management and rehabilitation, part II: specialty care and therapeutics. Foreword |
| Q89274849 | Physical exercise in adults with hereditary neuromuscular disease |
| Q71836766 | Physical models of rehabilitation in neuromuscular disease |
| Q98898319 | Pitfalls in the interpretation of pulmonary function tests in neuromuscular disease |
| Q79761394 | Place of orthotic devices in the neuromuscular diseases |
| Q64946575 | Pneumothorax in neuromuscular disease associated with lung volume recruitment and mechanical insufflation-exsufflation. |
| Q37364904 | Pompe disease: a neuromuscular disease with respiratory muscle involvement |
| Q72756827 | Posterior allograft bone-block for recurrent dislocation of the hip after hemiarthroplasty in noncompliant patients with neuromuscular disease |
| Q90285798 | Practical Implementation of a Single-Night Split-Titration Protocol With BPAP-ST and AVAPS in Patients With Neuromuscular Disease |
| Q51745084 | Predictors of health-related quality of life in adult ambulatory independence neuromuscular disease patients |
| Q93097995 | Preliminary Effectiveness and Safety of High Frequency Oscillation in Addition to Mechanical Insufflation and Exsufflation for Intratracheal Mucus Removal in Patients With Neuromuscular Disease: Protocol for a Prospective Study |
| Q74298409 | Pressure-controlled ventilation via a mini-tracheostomy tube for patients with neuromuscular disease |
| Q53092248 | Prevalence of Vitamin D Deficiency in Spring and Summer Months in Central Pennsylvania Neuromuscular Clinic: A Study Complementary to the Pilot Study Published in Journal of Clinical Neuromuscular Disease in June 2015 for Fall and Winter Months. |
| Q82561953 | Preventive non-invasive ventilation is indicated for neuromuscular disease patients after extubation |
| Q42261573 | Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: clinical and muscle biopsy findings and treatment with alpha-tocopherol |
| Q70274631 | Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: diagnosis and treatment with alpha tocopherol |
| Q104136533 | Psychological Case Conference Following the Death of a Patient With Neuromuscular Disease: A Source of Emotional Support for Participating Medical Staff |
| Q40927211 | Psychometric properties of the Duke Health Profile in a neuromuscular disease population |
| Q82701404 | Pulmonary complications of neuromuscular disease: a respiratory mechanics perspective |
| Q70309487 | Pulmonary function in moderate neuromuscular disease without respiratory complaints |
| Q104130247 | Pulmonary function testing in patients with neuromuscular disease |
| Q73444993 | Pulmonary manifestations of neuromuscular disease |
| Q36523067 | Pulmonary rehabilitation in patients with neuromuscular disease. |
| Q67693699 | Pyruvate kinase: diagnostic value in neuromuscular disease |
| Q70605686 | Quantitative electromyography in babies and young children with no evidence of neuromuscular disease |
| Q73437307 | Quantitative skeletal muscle ultrasonography in children with suspected neuromuscular disease |
| Q80404917 | Quantitative skeletal muscle ultrasound: diagnostic value in childhood neuromuscular disease |
| Q26864907 | Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies |
| Q60679072 | Referral of patients with neuromuscular disease to occupational therapy, physical therapy and speech therapy: Usual practice versus multidisciplinary advice |
| Q89705531 | Reflections on 50 Years of Neuroscience Nursing: Movement Disorders, Neuromuscular Disease, and Multiple Sclerosis |
| Q28587199 | Regionalized neurofilament accumulation and motoneuron degeneration are linked phenotypes in wobbler neuromuscular disease |
| Q24188246 | Rehabilitation interventions for foot drop in neuromuscular disease |
| Q24239961 | Rehabilitation interventions for foot drop in neuromuscular disease |
| Q24245426 | Rehabilitation interventions for foot drop in neuromuscular disease |
| Q37591771 | Rehabilitation management of neuromuscular disease: the role of exercise training |
| Q30401336 | Rehabilitation of the pediatric patient with a neuromuscular disease |
| Q47860881 | Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights |
| Q41741563 | Relationship of reproductive hormones and neuromuscular disease of the gastrointestinal tract |
| Q28395090 | Relationships among alexithymia and pain intensity, pain interference, and vitality in persons with neuromuscular disease: Considering the effect of negative affectivity |
| Q58132770 | Report on the 4th Ottawa International Conference on Neuromuscular Disease and Biology - September 5-7, 2017, Ottawa, Canada |
| Q72957313 | Research in neuromuscular disease |
| Q92170467 | Respiratory Care of Patients With Neuromuscular Disease |
| Q58589279 | Respiratory adjuncts to NIV in neuromuscular disease |
| Q39198401 | Respiratory complications, management and treatments for neuromuscular disease in children |
| Q67649544 | Respiratory failure as a complication of neuromuscular disease |
| Q91060278 | Respiratory health service utilization of children with neuromuscular disease |
| Q50188900 | Respiratory insufficiency in patients with progressive neuromuscular disease can sometimes be treated effectively with ventilatory support |
| Q87302892 | Respiratory involvement in neuromuscular disease |
| Q90531342 | Respiratory management of patients with neuromuscular disease: current perspectives |
| Q48685106 | Respiratory monitoring in neuromuscular disease - capnography as an additional tool? |
| Q24188193 | Respiratory muscle training in children and adults with neuromuscular disease |
| Q93125839 | Respiratory muscle training in children and adults with neuromuscular disease |
| Q54069945 | Respiratory muscle training in neuromuscular disease: long-term effects on strength and load perception. |
| Q36846953 | Respiratory support for the severely handicapped child with neuromuscular disease: ethics and practicality |
| Q46775041 | Results of muscular x-ray computed tomography in 145 cases of neuromuscular disease |
| Q74545441 | Retinitis pigmentosa, acanthrocytosis, and heredodegenerative neuromuscular disease |
| Q41088887 | Role of exercise in the assessment and management of neuromuscular disease in children |
| Q47603524 | Role of noninvasive ventilation in perioperative patients with neuromuscular disease: a clinical case |
| Q92152482 | S1P/S1P Receptor Signaling in Neuromuscolar Disorders |
| Q77156506 | SOFT TISSUE RADIOGRAPHY OF EXTREMITIES IN NEUROMUSCULAR DISEASE WITH HISTOLOGICAL CORRELATIONS |
| Q92822739 | Safety of intravenous immune globulin in an outpatient setting for patients with neuromuscular disease |
| Q37320941 | Same-day physical therapy consults in an outpatient neuromuscular disease physician clinic |
| Q82833403 | Scoliosis surgery in children with neuromuscular disease: findings from the US National Inpatient Sample, 1997 to 2003 |
| Q48351444 | Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis |
| Q89635918 | Self-management program improves participation in patients with neuromuscular disease: A randomized controlled trial |
| Q90388996 | Self-management program improves participation in patients with neuromuscular disease: A randomized controlled trial |
| Q80404925 | Sensitivity and specificity of qualitative muscle ultrasound in assessment of suspected neuromuscular disease in childhood |
| Q72648666 | Severe hypercapnia after low-flow oxygen therapy in patients with neuromuscular disease and diaphragmatic dysfunction |
| Q71827734 | Sexuality and neuromuscular disease: a pilot study |
| Q73598633 | Should patients with neuromuscular disease be denied the choice of the treatment of mechanical ventilation? |
| Q97534638 | Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine |
| Q72392313 | Single-incision combination biopsy (muscle and nerve) in the diagnosis of neuromuscular disease in children |
| Q31142754 | Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials |
| Q31128471 | Skeletal muscle imaging in neuromuscular disease |
| Q47749651 | Sleep abnormalities associated with neuromuscular disease: pathophysiology and evaluation |
| Q36318491 | Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease |
| Q50993850 | Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population. |
| Q39217430 | Sleep-Disordered Breathing in Neuromuscular Disease: Diagnostic and Therapeutic Challenges. |
| Q67448328 | Some changing concepts in neuromuscular disease |
| Q59557965 | Sonographically Guided Percutaneous Muscle Biopsy in Diagnosis of Neuromuscular Disease |
| Q59557957 | Sonographically guided percutaneous muscle biopsy in diagnosis of neuromuscular disease: a useful alternative to open surgical biopsy |
| Q62788345 | Sparse Classification with MRI Based Markers for Neuromuscular Disease Categorization |
| Q48161421 | Spinal anesthesia is a valid alternative to other anesthetic approaches for children with neuromuscular disease, and dexmedetomidine sedation is a safe method for pediatric regional anesthesia |
| Q83046506 | Spinal decompensation in neuromuscular disease |
| Q64767158 | Spontaneous Restoration of Nutrition Autonomy in a Case of Intestinal Failure Secondary to a Gastrointestinal Neuromuscular Disease |
| Q33660403 | Stability and relative validity of the Neuromuscular Disease Impact Profile (NMDIP) |
| Q68273640 | Static and progressive neuromuscular disease in a kindred |
| Q48539510 | Stress Fracture of the Fifth Metatarsal in Foot Deformity Secondary to Neuromuscular Disease: Experiences of Deformity Correction Treatment-A Report of 3 Cases and Review of the Literature |
| Q66973402 | Stress in families of children with neuromuscular disease |
| Q73268473 | Studies in neuromuscular disease with radioactive potassium |
| Q41159599 | Successful Extubation After Weaning Failure by Noninvasive Ventilation in Patients With Neuromuscular Disease: Case Series. |
| Q88740385 | Swallowing and Secretion Management in Neuromuscular Disease |
| Q66857132 | Symposium on care of the patient with neuromuscular disease |
| Q91734781 | Teaching Manually Assisted Cough to Caregivers of Children With Neuromuscular Disease |
| Q93719171 | Techniques for the demonstration of human muscle spindle innervation in neuromuscular disease |
| Q41774454 | Telemedicine system for the care of patients with neuromuscular disease and chronic respiratory failure. |
| Q90285786 | The Accuracy of an Ambulatory Level III Sleep Study Compared to a Level I Sleep Study for the Diagnosis of Sleep-Disordered Breathing in Children With Neuromuscular Disease |
| Q92619576 | The Autophagy Signaling Pathway: A Potential Multifunctional Therapeutic Target of Curcumin in Neurological and Neuromuscular Diseases |
| Q99410972 | The Canadian Neuromuscular Disease Registry 2010-2019: A Decade of Facilitating Clinical Research Through a Nationwide, Pan-Neuromuscular Disease Registry |
| Q57040525 | The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities |
| Q91849466 | The First Reported Case of Infant Botulism in Korea: Treatable Infantile Neuromuscular Disease |
| Q98939378 | The Impact of Lung Volume Recruitment on Pulmonary Function in Progressive Childhood Onset Neuromuscular Disease: A Systematic Review |
| Q93633810 | The Neuromuscular Disease Center: www.neuro.wustl.edu/neuromuscular |
| Q108591447 | The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease |
| Q38628798 | The New Zealand Neuromuscular Disease Patient Registry; Five Years and a Thousand Patients |
| Q64039897 | The New Zealand Neuromuscular Disease Registry |
| Q38393651 | The New Zealand Neuromuscular Disease Registry: rate of diagnoses confirmed by molecular testing. |
| Q44743743 | The Ryukyuan muscular atrophy. An obscure heritable neuromuscular disease found in the islands of southern Japan |
| Q35843569 | The Significance of Transcutaneous Continuous Overnight CO(2) Monitoring in Determining Initial Mechanical Ventilator Application for Patients with Neuromuscular Disease |
| Q71227916 | The assessment of muscle mass in progressive neuromuscular disease |
| Q94544651 | The effect of 50% oxygen on PtCO2 in patients with stable COPD, bronchiectasis, and neuromuscular disease or kyphoscoliosis: randomised cross-over trials |
| Q72649435 | The effect of ventilatory muscle training on respiratory function and capacity in ambulatory and bed-ridden patients with neuromuscular disease |
| Q73771707 | The inheritance of neuromuscular disease |
| Q26853440 | The ipsilesional upper limb can be affected following stroke |
| Q69991756 | The many faces of neuromuscular disease |
| Q47853195 | The new neuromuscular disease related with defects in the ASC-1 complex: report of a second case confirms ASCC1 involvement |
| Q71624835 | The prevalence of inherited neuromuscular disease in Northern Ireland |
| Q38770622 | The prevalence of neuromuscular disease in the paediatric population in Yorkshire, UK; variation by ethnicity and deprivation status |
| Q47579115 | The quality of life in genetic neuromuscular disease questionnaire: Rasch validation of the French version |
| Q35231837 | The recent understanding of the neurotrophin's role in skeletal muscle adaptation |
| Q70373988 | The recognition and management of respiratory insufficiency in neuromuscular disease |
| Q51556414 | The reliability and validity of a self-report version of the FIM instrument in persons with neuromuscular disease and chronic pain. |
| Q44967227 | The role of patient advocacy organisations in neuromuscular disease R&D--The case of the Dutch neuromuscular disease association VSN. |
| Q77810806 | The role of physiatry in the management of neuromuscular disease |
| Q47231938 | The role of tRNA synthetases in neurological and neuromuscular disorders |
| Q36351131 | The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease |
| Q44607582 | The serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis. |
| Q84499215 | The short-term effects of intermittent positive pressure breathing treatments on ventilation in patients with neuromuscular disease |
| Q43787249 | The significance of increased creatine-kinase activity in the serum of patients without primary neuromuscular disease |
| Q67429635 | The significance of ragged-red fibres in neuromuscular disease |
| Q73169808 | The thyroid gland in relation to neuromuscular disease |
| Q73414352 | The thyroid gland in relation to neuromuscular disease |
| Q50592364 | The utility of genetic testing in neuromuscular disease: A consensus statement from the AANEM on the clinical utility of genetic testing in diagnosis of neuromuscular disease. |
| Q73445670 | The value of electrodiagnostic methods in the investigation of neuromuscular disease |
| Q74261502 | Therapy in neuromuscular disease |
| Q104559504 | Three Individuals with PURA Syndrome in a Cohort of Patients with Neuromuscular Disease |
| Q72802888 | Thyroxine-responsive unilateral forelimb lameness and generalized neuromuscular disease in four hypothyroid dogs |
| Q68761536 | Torsion infarction in ectopic cryptorchidism: a rare entity occurring most commonly with spastic neuromuscular disease |
| Q52401800 | Total hip arthroplasty in patients with neuromuscular imbalance. |
| Q41866859 | Totally absorbable screws in fixation of subtalar extra articular arthrodesis in children with spastic neuromuscular disease: preliminary report of a randomized prospective study of fourteen arthrodeses fixed with absorbable or metallic screws |
| Q91748932 | Transition of patients with neuromuscular disease and chronic ventilator-dependent respiratory failure from pediatric to adult pulmonary care |
| Q92131999 | Transition to adult care in young people with neuromuscular disease on non-invasive ventilation |
| Q52756417 | Treating pediatric neuromuscular disorders: The future is now. |
| Q64121112 | Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: A population-based retrospective cohort study (2003-2014) |
| Q67355186 | Triosephosphate isomerase deficiency with hemolytic anemia and severe neuromuscular disease: familial and biochemical studies of a case found in Spain |
| Q64907087 | Two-minute versus 6-minute walk distances during 6-minute walk test in neuromuscular disease: Is the 2-minute walk test an effective alternative to a 6-minute walk test? |
| Q69906403 | Type I muscle fibre atrophy and central nuclei. A rare familial neuromuscular disease |
| Q58252450 | Ultrasound guided needle biopsy of skeletal muscle in neuromuscular disease |
| Q79529641 | Unit electromyography in neuromuscular disease |
| Q68430645 | Unknown cause of familial neuromuscular disease with infiltration of cytotoxic/suppressor T cells |
| Q37342962 | Upregulation of PKD1L2 provokes a complex neuromuscular disease in the mouse |
| Q79654157 | Use of functional electrotherapy in neuromuscular disease |
| Q73434958 | Use of gold weights to correct lagophthalmos in neuromuscular disease |
| Q34312707 | Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough |
| Q38058628 | Using palliative care in progressive neuromuscular disease to maximize quality of life |
| Q68268639 | Value of EMG in neuromuscular diseases seen in an otoneurology department |
| Q70066520 | Variability in limb malformations and possible significance in the pathogenesis of an inherited congenital neuromuscular disease of Charolais cattle (syndrome of arthrogryposis and palatoschisis) |
| Q68412667 | Ventilator use in progressive neuromuscular disease: impact on patients and their families |
| Q51569510 | Vital Capacity Impairment due to Neuromuscular Disease and its Correlation with Diaphragmatic Ultrasound: A Preliminary Study. |
| Q89980739 | Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease |
| Q73338435 | Walking speed in children and young adults with neuromuscular disease: comparison between two assessment methods |
| Q44644348 | Wavelet domain feature extraction scheme based on dominant motor unit action potential of EMG signal for neuromuscular disease classification |
| Q70280209 | Weaning failure due to acute neuromuscular disease |
| Q91129301 | Weaning from mechanical ventilation in people with neuromuscular disease: protocol for a systematic review |
| Q68273673 | X-linked recessive humero-peroneal neuromuscular disease associated with atrial paralysis and sudden death |
| Q70584534 | [A case of oculocraniosomatic neuromuscular disease with "ragged-red" fibers] |
| Q95529788 | [A neuromuscular disease clinical model] |
| Q95500919 | [Acute respiratory failure in neuromuscular disease] |
| Q87297641 | [Characteristics of neuromuscular disease related sleep disordered breathing] |
| Q84093631 | [Clinical trials in child neuromuscular disease] |
| Q84390619 | [Congenital neuromuscular disease with uniform type 1 fiber complicated by brain atrophy: a case report] |
| Q52236939 | [Congenital neuromuscular disease with uniform type 1 fibers : a case report] |
| Q80814757 | [Cough--assistance--ventilation: mechanical aids and assisted cough for patients with neuromuscular disease] |
| Q73219302 | [Diagnosis and therapy of vasculitic neuropathy. Consensus statement of the German Centers for Neuromuscular Disease] |
| Q80814778 | [Diagnosis and treatment of dysphagia in patients with neuromuscular disease] |
| Q71633729 | [Diagnostic value of serum myoglobin in cases of neuromuscular disease] |
| Q81249329 | [Effect of thoracic bracing on lung function in children with neuromuscular disease] |
| Q80393695 | [Fatigue in neuromuscular disease] |
| Q70360879 | [Fluorescence histochemical study of catecholamine concentrations in the skeletal muscles of patients with different forms of progressive neuromuscular disease] |
| Q93651066 | [Home artificial respiration of patients with a chronic neuromuscular disease] |
| Q83107274 | [Long term domiciliary mechanical ventilation in patients with neuromuscular disease (indications, establishment and follow up)] |
| Q69702214 | [Moments of psychological crisis in patients with neuromuscular disease and factors favoring the reactions of adaptation to progressive motor disability] |
| Q70531097 | [Muscle histochemistry as a modern approach in the study of neuromuscular disease (author's transl)] |
| Q73273152 | [Myasthenia gravis--an autoimmune neuromuscular disease] |
| Q86709696 | [Neuromuscular disease and sleep disturbance] |
| Q78902853 | [Neuromuscular disease in relation to nutrition] |
| Q68420592 | [Neuromuscular disease: a view on viewpoints] |
| Q73360413 | [Neuromuscular disease: health care accessibility in the Nord-Pas-de- Calais region] |
| Q87629865 | [Neuromuscular disease: respiratory clinical assessment and follow-up] |
| Q69209842 | [Nuclear magnetic resonance imaging in neuromuscular disease] |
| Q70430780 | [Oculocraniosomatic neuromuscular disease, a multisystem disease with abnormal mitochondria demonstrated in skeletal muscle and liver (author's transl)] |
| Q73631452 | [Recommendations of Bavarian Muscle Centers of the German Neuromuscular Disease Society for home ventilation of neuromuscular diseases of adult patients] |
| Q79290274 | [Recommendations of HAS: Practical issues in home non-invasive ventilation in patients with neuromuscular disease] |
| Q94499450 | [Recommendations of HAS: Practical issues in home non-invasive ventilation in patients with neuromuscular disease] |
| Q94499456 | [Recommendations of HAS: Practical issues in home non-invasive ventilation in patients with neuromuscular disease] |
| Q81449227 | [Removal of a tracheostomy in ventilator-dependent patients with neuromuscular disease] |
| Q88809443 | [Respiratory care in patient with neuromuscular disease: the existing and the desirable] |
| Q88009072 | [Respiratory treatments in neuromuscular disease] |
| Q76378567 | [Stem cells and neuromuscular disease] |
| Q67960080 | [The significance of increased serum creatine kinase activity in patients without primary neuromuscular disease] |
| Q80271401 | [Treatment of patients with neuromuscular disease in a warm climate] |
| Q81237954 | [Twenty-five years of the Neuromuscular Disease Reference Center of the German Society for Neuropathology and Neuroanatomy] |
| Q70137227 | [Two siblings of familial "oculocraniosomatic neuromuscular disease with ragged-red fibers" due to a partial cytochrome c oxidase deficiency] |
| Q15324120 | TRPV4 | genetic association | P2293 |
| Q98971873 | Category:Neuromuscular diseases | category's main topic | P301 |
| Arabic (ar / Q13955) | اضطراب عصبي عضلي | wikipedia |
| Catalan (ca / Q7026) | Malaltia neuromuscular | wikipedia |
| Neuromuskuläre Erkrankung | wikipedia | |
| Neuromuscular disease | wikipedia | |
| en-simple | Category:Muscle diseases | wikipedia |
| Maladie neuromusculaire | wikipedia | |
| Malattia neuromuscolare | wikipedia | |
| 신경근육질환 | wikipedia | |
| Spierziekte | wikipedia | |
| Doença neuromuscular | wikipedia | |
| Neuromišićne bolesti | wikipedia | |
| Neuromuskulära sjukdomar | wikipedia |
Search more.